Procedures, process and testing designed to prevent microbial contamination of the drug product purporting to be sterile are not established.
Inspection Record
Genzyme Ireland Limited — FDA 483 Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
The “systems in support of ®®drug product manufacture are not adequately maintained.
Equipment used in the QC Microbiological Lab is not adequately maintained.
A standard operating procedure was not followed.
A record as of the US FDA document published on 2026-11-12. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.